Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
ClinicalTrials.gov study NCT02835235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC
ClinicalTrials.gov study NCT05520853. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors
ClinicalTrials.gov study NCT02930967. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05766800. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06567600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
ClinicalTrials.gov study NCT05520814. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
ClinicalTrials.gov study NCT01563068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection
ClinicalTrials.gov study NCT03588923. IPD Sharing: NO. Countries: 1. Publications: 0.
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06740370. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (
ClinicalTrials.gov study NCT06345729. IPD Sharing: YES. Countries: 27. Publications: 0.
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
ClinicalTrials.gov study NCT04892953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer
ClinicalTrials.gov study NCT03983057. IPD Sharing: NO. Countries: 1. Publications: 0.
Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)
ClinicalTrials.gov study NCT07277764. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.
ClinicalTrials.gov study NCT05960240. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
ClinicalTrials.gov study NCT06826079. IPD Sharing: NO. Countries: 1. Publications: 0.
TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04297280. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
ClinicalTrials.gov study NCT05549466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
ClinicalTrials.gov study NCT05886439. IPD Sharing: NO. Countries: 1. Publications: 0.
Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
ClinicalTrials.gov study NCT05545436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
ClinicalTrials.gov study NCT05108038. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.